ICNSl logo no-tagline copy

PEER REVIEWED, EVIDENCE-BASED INFORMATION FOR CLINICIANS AND RESEARCHERS IN NEUROSCIENCE

CURRENT ISSUE

ICNS_Mar_Apr_2015_cover
Editor's Message and Issue Highlights—March–April 2015
Dear Colleagues: Welcome to the March–April 2015 issue of Innovations in Clinical Neuroscience (ICNS)....
Read More
Bipeta_Mar_Apr_2015_art
Diagnostic Stability of Internet Addiction in Obsessive-compulsive Disorder: Data from a Naturalistic One-year Treatment Study
by Rajshekhar Bipeta, MBBS, DPM, DNB (psych); Srinivasa SRR Yerramilli, MD (psych); Ashok Reddy Karredla,...
Read More
Lippmann_Mar_Apr_2015_Art
Atypical Myopathy: Pentazocine Induced
by Murali K. Kolikonda, MD; Suneela Cherlopalle, MD; Manasa Enja, MD; and Steven Lippmann, MD Drs. Kolikonda,...
Read More
Wadekar_Mar_Apr_2015_Art
Patient-centered Outcomes Research (PCOR): How Can We Optimize Outcomes in CNS Research?
by Mitali Wadekar, MD; Anil Sharma, MD, MBA; and Gina Battaglia, PhD Drs. Wadekar and Sharma are with...
Read More
Sansone_Mar_Apr_2015_Art
Buprenorphine Treatment for Narcotic Addiction: Not Without Risks
by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry...
Read More
Risk_Mar_Apr_2015_art
Avoiding Risk With Nonadherent Patients
by Ann McNary, JD Ms. McNary is Senior Risk Manager, Professional Risk Management Services, Arlington,...
Read More
A message from the chair, ISCTM Scientific Publications
Dear Colleagues: Twice a year, the International Society for CNS Clinical Trials and Methodology (ISCTM)...
Read More
Translational and Early Phase Strategies for Treatment Development: Report of ISCTM Autumn 2013 Symposium
by Jared W. Young, PhD; William Z. Potter, MD, PhD; Steve Riley, PharmD, PhD; Geert J. Groeneveld, MD,...
Read More
Lessons Learned and Potentials for Improvement in CNS Drug Development: ISCTM Section on Designing the Right Series of Experiments
by Steven T. Szabo, MD, PhD; Bruce J. Kinon, MD; Stephen K. Brannan, MD; Andrew K. Krystal, MD, MSc;...
Read More
Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia
by Harald Murck, MD, PhD; Thomas Laughren, MD; Femke Lamers, PhD; Rosalind Picard, ScD; Sebastian Walther,...
Read More

LATEST DIGITAL EDITION

ARCHIVES